CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,679,242 | +4.9% | 125,121 | +29.7% | 0.00% | 0.0% |
Q2 2023 | $5,415,882 | -10.8% | 96,471 | -28.1% | 0.00% | 0.0% |
Q1 2023 | $6,070,318 | +111.5% | 134,210 | +90.1% | 0.00% | +100.0% |
Q4 2022 | $2,869,484 | +568.9% | 70,590 | +974.4% | 0.00% | – |
Q3 2022 | $429,000 | -93.7% | 6,570 | -94.1% | 0.00% | -100.0% |
Q2 2022 | $6,770,000 | -87.4% | 111,415 | -87.0% | 0.00% | -83.3% |
Q1 2022 | $53,641,000 | -28.3% | 854,579 | -13.4% | 0.02% | -28.0% |
Q4 2021 | $74,823,000 | -16.5% | 987,378 | +23.3% | 0.02% | -21.9% |
Q3 2021 | $89,621,000 | -57.2% | 800,696 | -38.0% | 0.03% | -61.0% |
Q2 2021 | $209,172,000 | +35.6% | 1,292,061 | +2.0% | 0.08% | +7.9% |
Q1 2021 | $154,298,000 | +14.0% | 1,266,286 | +43.2% | 0.08% | +11.8% |
Q4 2020 | $135,388,000 | +424.1% | 884,249 | +186.3% | 0.07% | +353.3% |
Q3 2020 | $25,832,000 | +16.2% | 308,843 | +2.1% | 0.02% | -6.2% |
Q2 2020 | $22,231,000 | +951.6% | 302,494 | +506.8% | 0.02% | +700.0% |
Q1 2020 | $2,114,000 | +13.5% | 49,850 | +63.1% | 0.00% | -50.0% |
Q4 2019 | $1,862,000 | +231.9% | 30,565 | +156.7% | 0.00% | +300.0% |
Q2 2019 | $561,000 | +150.4% | 11,907 | +90.2% | 0.00% | – |
Q1 2019 | $224,000 | -80.0% | 6,261 | -84.1% | 0.00% | -100.0% |
Q4 2018 | $1,122,000 | -71.1% | 39,274 | -55.2% | 0.00% | -75.0% |
Q3 2018 | $3,886,000 | +194.4% | 87,626 | +290.3% | 0.01% | +166.7% |
Q2 2018 | $1,320,000 | +49.0% | 22,452 | +15.9% | 0.00% | +50.0% |
Q1 2018 | $886,000 | – | 19,373 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |